Dionex has announced a method that the company reports can fully recover low concentrations of three microcystins when added to water samples.
Dionex has announced a method that the company reports can fully recover low concentrations (
Microcystin contamination of drinking water at low nanomolar concentrations is considered a risk factor for cancer; therefore, the World Health Organization (WHO) has proposed a provisional guideline concentration of 1.0 μg/L for microcystin-LR in drinking water.
The company’s Application Note 261: Sensitive Determination of Microcystins in Drinking and Environmental Waters is reported to demonstrate recovery at lower concentrations than the maximum recommended by WHO. The company claims that this method is fully automated and easily configured on an UltiMate 3000 ×2 Dual HPLC system, using Acclaim PA2 columns for solid-phase extraction (SPE) and analysis.
This new target-cut on-line SPE method with dual function (analyte capture and partial separation) operates under automatic control of Chromeleon Chromatography Data System (CDS) software and offers full automation, absence of operator influence and strict process control.
For the application note, click here.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.